<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did NEPH's Q4 2024 forecast compare to past quarters?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/9/2025 02:33pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Nephros (NEPH) faced a challenging fourth quarter in 2024, with forecasted revenue significantly lower than the previous quarter's estimates. Here's a comparison of the estimated revenue for Q4 2024 with the previous three quarters:

1. **Q4 2024**: The estimated revenue for Q4 2024 was $3.5 million.
2. **Q3 2024**: The estimated revenue for Q3 2024 was $3.85 million.
3. **Q2 2024**: There are no available estimates for Q2 2024, but the estimated revenue for Q3 2024 was higher than Q2 2024, indicating a potential decline in revenue from Q2 to Q3.
4. **Q1 2024**: There are no available estimates for Q1 2024, but given that Q3's revenue was $3.85 million, it suggests that Q1's revenue might have been even lower than Q4's $3.5 million, if any estimates were made.

The data indicates a concerning trend of potentially decreasing revenue from the previous quarter, with Q4's estimates being the lowest among the four quarters. This could signal operational challenges or market conditions that affected Nephros' financial performance during this period.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq){return {layout:"default",data:[{noData:c,currentQuestion:f,textDescription:I,comeFrom:"AInvestShareLink",events:[],answerSource:n}],fetch:{},error:o,state:{sharePreviewModule:{loadJgySuccess:d,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:p,agent_id:a,output_media_info:[],task_id:a,language:a,source:n,cache_builder:a,reply_action:"Answer",execute_mode:B,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did NEPH's Q4 2024 forecast compare to past quarters?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did NEPH's Q4 2024 forecast compare to past quarters?\",\"user_id\":\"dp67706582\",\"user_name\":\"\",\"trace_id\":\"4045093c-9f3e-4004-941e-8c5cda103242\",\"session_id\":\"4045093c-9f3e-4004-941e-8c5cda103242\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:J,query_type:k,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Estimate Revenue[20240930]|Report End Date[20240930]|\n|---|---|---|---|---|---|\n|NEPH|Nephros|$1.81|-7.18%|$3.5 million|20240930|\n",query_data:{number:K,title:C,query_type:k,condition:a,model_sql:L,data_ext_params:{merge_repeat:c,expand_index:b,data_add:p,add_index:d}}},{info_type:J,query_type:k,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Estimate Revenue[20240630]|Report End Date[20240630]|\n|---|---|---|---|---|---|\n|NEPH|Nephros|$1.81|-7.18%|$3.85 million|20240630|\n",query_data:{number:v,title:D,query_type:k,condition:a,model_sql:M,data_ext_params:{merge_repeat:c,expand_index:b,data_add:p,add_index:d}}}],answer_chain_name:N,agent_mode:O,native_answer:a,come_from:a,text_answer:I,trace_id:g,cost:17806,event_names:a,question:f,fallback_type:P,input_type:Q,fall_back_reason:{fall_back_type:P,risk_detail:{matched_words:[]}},session_id:g,first_return_cost:3449,cache_type:a,question_id:g,transfer_question:f,signal_type:"ON_COMPLETE",start_time:R,remote_svc:n,slots:[],answer_type:B,user_id:w,skill_name:E},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:g,session_id:g,user_id:w,question:f,source:n,raw_question:f,version:"3.4.1",action_name:E,nlu:{entity:[{type:S,value:"NEPH.O",market:T}]},deep_research:c,deep_thinking:c,agent_mode:O},extra:{}},{answer_path:h,section:{id:i,info_texts:["Thinking"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: NEPH Forecasted Revenue in Q4 2024"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:y,action_input:"NEPH Forecasted Revenue in Q4 2024",thought:z}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: NEPH Forecasted Revenue in Q3 2024"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:y,action_input:C,thought:z}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: NEPH Forecasted Revenue in Q2 2024"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:y,action_input:D,thought:z}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: NEPH Forecasted Revenue in Q1 2024"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:y,action_input:"NEPH Forecasted Revenue in Q1 2024",thought:z}},{answer_path:e,section:{id:U,info_texts:[],show_type:F,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:U,info_texts:[],show_type:F,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Generating Answer"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:e,section:{id:q,info_texts:[],show_type:l,voice_txt:"N",text_answer:V,rich_text:V,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"NEPH",market_id:T,name:W,domain:S},pos:d,section_id:q,txt:W,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:q,info_texts:[],show_type:l,voice_txt:X,text_answer:Y,rich_text:Y,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:Z,info_texts:[],show_type:l,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:C,query_type:k,trace_data:a,index:K,model_sql:L,data_ext_params:{merge_repeat:c,expand_index:b,data_add:p,add_index:d},jump_type:_}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:q,info_texts:[],show_type:l,voice_txt:".\n2",text_answer:$,rich_text:$,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:Z,info_texts:[],show_type:l,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:D,query_type:k,trace_data:a,index:v,model_sql:M,data_ext_params:{merge_repeat:c,expand_index:b,data_add:p,add_index:d},jump_type:_}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:q,info_texts:[],show_type:l,voice_txt:".\n3",text_answer:aa,rich_text:aa,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:h,section:{id:i,info_texts:["Completed"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:r,query_text:r,trace_info:{item_id:"052f3bf857ad89d8b878eef5a9b7b57e",item_type:m,item_name:r,rec_info:ab}},{display_text:s,query_text:s,trace_info:{item_id:"db4955b02500fea1bdc1d3015c6b7023",item_type:m,item_name:s,rec_info:ac}},{display_text:t,query_text:t,trace_info:{item_id:"817d20d8cba24ac7a702aca07026ad20",item_type:m,item_name:t,rec_info:ad}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:d,type:X,display2:c,url:a}},request_config:[{source_type:v,related_name:ae}],puuid:G,tag:a,category:"custom",uuid:af}],global:{urp_static_data:[{name:ae,value:{status_code:d,columns:[{type:u,index_name:ag,key:ag},{type:u,index_name:ah,key:ah},{type:u,index_name:ai,key:ai},{type:u,index_name:aj,key:aj},{type:u,index_name:ak,key:ak}],datas:[{send_text:r,item_type:m,rec_info:ab,display_text:r,rec_reason:a},{send_text:s,item_type:m,rec_info:ac,display_text:s,rec_reason:a},{send_text:t,item_type:m,rec_info:ad,display_text:t,rec_reason:a}],dataSize:v,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:al,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:A,"min-height":"100%",position:am,height:A},isMaterial:c,id:al,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:d,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:H,componentUuid:af,script:[{name:an,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:H,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:H},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:A,position:am,height:A},isMaterial:b,_id:19,id:an,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ao,voice_txt:a,tracking_info:{},uuid:G},order:{is_auto:c,render_for:ao,chart_type:"command",puuid:G}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:F,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:E,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:B,answer_chain_name:N},is_deep_research:c,deep_thinking:c,create_time:1744180412287},is_last:b}],questionItem:{data:{qStr:f,encodeFlag:c,imageData:o,docsData:[],quoteData:o},tplType:"question"},events:ap,agentId:a,param:{entity_info:{},add_info:{ori_question:f},event_list:ap,client_ip:a,question:f,user_id:w,user_name:a,trace_id:g,session_id:g,source:n,input_type:Q}}],userId:w,userName:a,startTime:R,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:o,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:d,traceTableData:o,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fnephs-q4-2024-forecast-compare-quarters-632348\u002F",config:{_app:{basePath:aq,assetsPath:aq,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,0,"other\u002FopenAnswer","How did NEPH's Q4 2024 forecast compare to past quarters?","4045093c-9f3e-4004-941e-8c5cda103242","progress\u002Fsearching_for",1000,"searching_for","intusstock","rich_text","llm_generated","ths_ainvest_lite_web",null,1,2001,"🤔 What were NEPH's earnings and revenue in Q4 2024?","🎯 What are the short-term price targets for NEPH?","⚙️ What are the key drivers of NEPH's Q4 2024 results?","STR",3,"dp67706582","thinking","Querying Stock","The user wants to compare NEPH's Q4 2024 forecast with past quarters. I should focus on the forecast data for Q4 2024 and previous quarters. I will use FinQuery for the data mentioned above.","auto","agent","NEPH Forecasted Revenue in Q3 2024","NEPH Forecasted Revenue in Q2 2024","review stocks","signal","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Nephros (NEPH) faced a challenging fourth quarter in 2024, with forecasted revenue significantly lower than the previous quarter's estimates. Here's a comparison of the estimated revenue for Q4 2024 with the previous three quarters:\n\n1. **Q4 2024**: The estimated revenue for Q4 2024 was $3.5 million.\n2. **Q3 2024**: The estimated revenue for Q3 2024 was $3.85 million.\n3. **Q2 2024**: There are no available estimates for Q2 2024, but the estimated revenue for Q3 2024 was higher than Q2 2024, indicating a potential decline in revenue from Q2 to Q3.\n4. **Q1 2024**: There are no available estimates for Q1 2024, but given that Q3's revenue was $3.85 million, it suggests that Q1's revenue might have been even lower than Q4's $3.5 million, if any estimates were made.\n\nThe data indicates a concerning trend of potentially decreasing revenue from the previous quarter, with Q4's estimates being the lowest among the four quarters. This could signal operational challenges or market conditions that affected Nephros' financial performance during this period.","query_data",2,"select   stock_code,   estimate_revenue from   ustock_fin_forecast where   report_end_date = date('2024y3q')   and stock_code = 'NEPH.O'","select   stock_code,   estimate_revenue from   ustock_fin_forecast where   report_end_date = date('2024y2q')   and stock_code = 'NEPH.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744180394481,"stock","186",999,"Nephros (NEPH) faced a challenging fourth quarter in 2024, with forecasted revenue significantly lower than the previous quarter's estimates. Here's a comparison of the estimated revenue for Q4 2024 with the previous three quarters:\n\n","Nephros","1","1. **Q4 2024**: The estimated revenue for Q4 2024 was $3.5 million[^2]",2000,"data_query",".\n2. **Q3 2024**: The estimated revenue for Q3 2024 was $3.85 million[^3]",".\n3. **Q2 2024**: There are no available estimates for Q2 2024, but the estimated revenue for Q3 2024 was higher than Q2 2024, indicating a potential decline in revenue from Q2 to Q3.\n4. **Q1 2024**: There are no available estimates for Q1 2024, but given that Q3's revenue was $3.85 million, it suggests that Q1's revenue might have been even lower than Q4's $3.5 million, if any estimates were made.\n\nThe data indicates a concerning trend of potentially decreasing revenue from the previous quarter, with Q4's estimates being the lowest among the four quarters. This could signal operational challenges or market conditions that affected Nephros' financial performance during this period.","2+679_496_21_554+0+0+4045093c-9f3e-4004-941e-8c5cda103242+052f3bf857ad89d8b878eef5a9b7b57e+llm_generated+aimeTagAnalysis+0+0.07590281963348389+1","2+679_496_21_554+0+0+4045093c-9f3e-4004-941e-8c5cda103242+db4955b02500fea1bdc1d3015c6b7023+llm_generated+aimeTagAnalysis+0+0.06758163124322891+2","2+679_496_21_554+0+0+4045093c-9f3e-4004-941e-8c5cda103242+817d20d8cba24ac7a702aca07026ad20+llm_generated+aimeTagAnalysis+0+0.05850977823138237+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>